Continuous Noninvasive Ventilatory Support and Mechanical Insufflation‐Exsufflation for Patients with Pediatric‐Onset Neuromuscular Disease: Improving Survival and Reducing Healthcare Burden
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.271_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von John L. Palmieri und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background and/or Objectives: Advances in disease-modifying therapies have altered the clinical course of pediatric-onset neuromuscular disorders such as Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD).Despite these advances, respiratory muscle weakness remains a leading cause of morbidity, hospitalization, and mortality in children and adolescents with severe neuromuscular ventilatory pump failure (VPF).This study evaluated long-term clinical outcomes associated with continuous noninvasive ventilatory support (CNVS) and mechanical insufflation-exsufflation (MIE) in individuals with advanced pediatric-onset neuromuscular disease, including those with minimal or absent ventilator-free breathing ability.
Design
Retrospective cohort analysis of longitudinal clinical outcomes from a specialized neuromuscular respiratory program.
Setting
Academic neuromuscular respiratory care center.
Participants
Individuals with advanced pediatric-onset neuromuscular diseases, including SMA, DMD, and other pediatric-onset neuromuscular disorders Interventions: CNVS and MIE for long-term ventilatory assistance and secretion management Main Outcome Measures: Survival, respiratory complications, hospitalization frequency, need for invasive ventilation, and tracheostomy avoidance.
Results
Pediatric patients with severe VPF, including those with markedly reduced or absent vital capacity, demonstrated prolonged survival using CNVS and MIE without tracheostomy ventilation.Long-term follow-up included 23 individuals with SMA type 1 supported with CNVS from infancy who are currently living over 30 years despite 0-mL vital capacity, and 57 individuals with DMD who survived beyond 40 years (including 14 beyond 50 years) while dependent on CNVS for decades without tracheostomy.This noninvasive respiratory rehabilitation approach also supported recovery from acute respiratory decompensation, with successful extubation to CNVS and MIE when respiratory failure was primarily attributable to neuromuscular weakness.
Zitieren
APA
Palmieri, J. L., & Bach, J. (2026). Continuous Noninvasive Ventilatory Support and Mechanical Insufflation‐Exsufflation for Patients with Pediatric‐Onset Neuromuscular Disease: Improving Survival and Reducing Healthcare Burden. PM&R, 18(S3). https://doi.org/10.1002/pmrj.271_70259
Vancouver
Palmieri JL, Bach J. Continuous Noninvasive Ventilatory Support and Mechanical Insufflation‐Exsufflation for Patients with Pediatric‐Onset Neuromuscular Disease: Improving Survival and Reducing Healthcare Burden. PM&R. 2026;18(S3). doi:10.1002/pmrj.271_70259
BibTeX
@article{Palmieri2026,
author = {Palmieri, John L. and Bach, John},
title = {Continuous Noninvasive Ventilatory Support and Mechanical Insufflation‐Exsufflation for Patients with Pediatric‐Onset Neuromuscular Disease: Improving Survival and Reducing Healthcare Burden},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.271_70259}
}
EUVIMED